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Reactive oxygen species (ROS) contribute to the
development of interstitial fibrosis and tubular atrophy
seen in chronic allograft nephropathy (CAN). As molecular
hydrogen gas can act as a scavenger of ROS, we tested the
effect of treatment with hydrogen water (HW) in a model
of kidney transplantation, in which allografts from Lewis
rats were orthotopically transplanted into Brown Norway
recipients that had undergone bilateral nephrectomy.
Molecular hydrogen was dissolved in water and recipients
were given HW from day 0 until day 150. Rats that were
treated with regular water (RW) gradually developed
proteinuria and their creatinine clearance declined, ultimately
leading to graft failure secondary to CAN. In contrast,
treatment with HW improved allograft function, slowed the
progression of CAN, reduced oxidant injury and
inflammatory mediator production, and improved overall
survival. Inflammatory signaling pathways, such as mitogen-
activated protein kinases, were less activated in renal
allografts from HW-treated rats as compared with RW-treated
rats. Hence, oral HW is an effective antioxidant and
antiinflammatory agent that prevented CAN, improved
survival of rat renal allografts, and may be of therapeutic
value in the setting of transplantation.
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Chronic kidney disease is the ninth leading cause of death in
the United States accounting for over 40,000 deaths
annually.1 Despite advances in renal replacement therapy,
transplantation remains the preferred treatment for suitable
candidates.2 However, in spite of improved postoperative
immunosuppression regimens, the 10-year graft survival
rates are 55 and 75% for cadaveric and live donor kidney
allografts, respectively. The vast majority of late failures
are attributable to chronic allograft nephropathy (CAN),
recently reclassified as interstitial fibrosis and tubular atrophy
with unknown etiology.3–6 The clinical course of CAN is
characterized by a progressive deterioration in renal function,
manifested by increasing renal hypertension and proteinuria.
Presently, no specific treatment is available for chronic
rejection in clinical transplantation despite a number of
successful approaches in animal models, including the use
of macrophage inhibitors, angiotensin converting enzyme
inhibitors, and endothelin A receptor antagonists.7–10
A number of factors contribute to the development of
CAN, including immunological (for example, acute
rejection) and nonimmunological (for example, ischemia-
reperfusion injury) factors.11,12 Oxidative stress is believed
to be a common pathway that leads to both immunological
and nonimmunological stress in the setting of kidney
transplantation and, ultimately, to the development of
CAN.13 Markers of oxidative stress, such as plasma lipid
peroxidases, are increased, whereas antioxidant markers,
including glutathione, superoxide dismutase, and glutathione
peroxidase, are decreased in the setting of CAN.14–17 Despite
this association, few studies have attempted to examine the
effect of antioxidants on kidney allograft outcomes and those
that have yielded mixed results. Vitamin E (a-tocopherol)
supplementation did not prevent allograft injury in a model
of CAN;16 however, in the same model, L-arginine did
attenuate proteinuria and glomerulosclerosis.18 Furthermore,
a clinical trial using recombinant human superoxide
dismutase resulted in significantly decreased acute and
chronic rejection.19 Therefore, based on the seemingly
conflicting results of these few studies, there is a need for
additional investigations into the applicability of antioxidants
for the prevention of CAN.
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Molecular hydrogen has recently been shown to have
therapeutic value as an antioxidant through its ability to
selectively reduce cytotoxic reactive oxygen species (ROS).20
Inhaled hydrogen gas (B4% H2 in air) can reduce infarct size
in rat models of focal cerebral and myocardial ischemia-
reperfusion injury.20,21 More recently, our group reported that
perioperative hydrogen inhalation (2%) significantly amelio-
rates intestinal transplant injury and prevents remote organ
inflammation through its antioxidant effects.22 Drinking
water containing a therapeutic dose of hydrogen (hydrogen
water; HW) represents an alternative mode of delivery
of molecular hydrogen. The primary advantages of HW are
that it is a portable, easily administered, and safe means
of delivering molecular hydrogen. Therefore, it may be of
potential therapeutic value in the treatment of oxidative
stress-induced pathologies. Interestingly, drinking HW, as well
as inhaling hydrogen gas, can alleviate cisplatin-induced
nephrotoxicity, which is known to be mediated, in part, by the
accumulation of ROS that occurs secondary to the ability of
cisplatin to inhibit the reducing form of glutathione23
Consumption of HW ad libitum prevents the development
of atherosclerosis in apolipoprotein E knockout mice, in part,
through its ability to limit the amount and deleterious effects
of oxidative stress in the blood vessels of these mice.24
Furthermore, a clinical trial in type II diabetic patients given
supplemental HW led to improved lipid and glucose
metabolism compared with controls.25 The aim of the present
study was to determine the efficacy of HW in preventing
CAN after allogeneic kidney transplantation in rats.
RESULTS
Oral administration of HW increased local and systemic levels
of hydrogen
To determine whether oral administration of HW results in
increased local or systemic levels of molecular hydrogen,
unoperated naı¨ve Lewis (LEW) rats were given HW to drink
and, subsequently, the concentration of molecular hydrogen
was measured in the kidney and in the serum. Both local and
systemic concentrations of molecular hydrogen peaked
B15min after ingestion (Figure 1a), proving that HW is an
effective mode of delivery of molecular hydrogen. We also
tested whether transplant recipients given long-term, daily HW
had increased concentrations of circulating hydrogen. Similar
kinetic changes in hydrogen concentration were observed in
both LEW recipients with LEW grafts (control rats; syngeneic
transplantation prevents CAN) and Brown Norway (BN)
recipients with LEW grafts treated with HW for 60 days
(Figure 1b). The baseline levels of the hydrogen detected in
circulation after 60 days of HW treatment was comparable to
that of naı¨ve animals, suggesting that there was no hydrogen
accumulation during long-term HW administration.
Oral administration of HW improves kidney function after
allotransplantation
We then sought to determine the effect of HW adminis-
tration on kidney function after allotransplantation. Isograft
recipients (LEW donor and LEW recipient) were included as
controls, as these rats do not develop CAN. Using a model of
kidney transplantation followed by bilateral nephrectomy, we
found that rats receiving daily HW ad libitum had improved
allograft function, as measured by blood urea nitrogen,
creatinine clearance, and proteinuria, compared with those
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Figure 1 |Hydrogen water (HW) administration improves
kidney allograft function. (a) Hydrogen-rich water (HW) (3ml)
was orally administered to naı¨ve Lewis (LEW) rats by gavage.
Arterial blood and kidney tissue were taken at 15, 30, and 60min
after oral administration of HW. Hydrogen concentration in blood
and homogenized kidney tissue increased within 15min and then
returned to the basal levels (n¼ 3). (*Po0.05 vs 0min).
(b) Kinetic analysis of the blood hydrogen levels after HW (3ml)
administration in the transplanted recipients that had been
given HW for 60 days were performed. Both isograft recipients
(n¼ 3) and allograft recipients (n¼ 3) showed similar changes
in circulating hydrogen concentrations. (c) Male LEW rats were
used as donors for either syngeneic (LEW recipient) or allogeneic
(Brown Norway recipient) renal transplantation. Recipients
were given either regular water (RW) or HW ad libitum after
transplantation, resulting in a total of four experimental groups:
isograft given RW (Iso/RW, n¼ 8) or HW (Iso/HW, n¼ 8); or allograft
given RW (Allo/RW, n¼ 18) or HW (Allo/HW, n¼ 17). The recipients
receiving daily HW had improved allograft function, as measured
by blood urea nitrogen (BUN), creatinine clearance (CCr), and 24h
urinary protein excretion, as compared with those receiving RW at
60 days posttransplantation. (*Po0.05 vs Allo/RW).
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receiving regular water (RW) at 60 days posttransplantation
(Figure 1c). These results suggest that HW can improve
kidney function after allotransplantation.
Oral administration of HW improves weight gain and overall
survival after allotransplantation
To determine whether the improved allograft function
that was observed in HW-treated recipients correlated with
global parameters of well being, we measured the weights of
transplant recipients and found that the majority of animals
that had undergone allotransplantation followed by admin-
istration of RW began to lose body weight B40 days after
transplantation. This process was significantly diminished
in the allograft recipients that received HW (Figure 2a).
Furthermore, we found that weight loss proved to be a
harbinger of allograft failure and, ultimately, of death.
HW-treated recipients exhibited a significant increase in
survival (median survival4 150 days) compared with
RW-treated controls (median survival 78 days) (Figure 2b).
These results show that the improved allograft function that
was observed at 60 days posttransplantation in HW-treated
recipients, as compared with RW-treated controls, also leads
to improved survival outcomes.
Oral administration of HW prevents the progression of CAN
To determine whether the improved allograft function and
overall survival observed in HW-treated animals were
attributable to decreased chronic rejection, histological
analysis was performed on allografts obtained 60 days
posttransplantation from both RW- and HW-treated reci-
pients. Hematoxylin and eosin staining of the allografts
obtained from HW-treated recipients exhibited decreased
evidence of the hallmarks of CAN, including less glomerulo-
sclerosis and inflammatory cell infiltration, as compared with
hematoxylin and eosin staining of allografts obtained from
RW-treated recipients (Figure 3a). Furthermore, Masson’s
trichrome staining and a-smooth muscle actin (aSMA)
staining on allografts obtained from HW-treated recipients
showed less interstitial fibrosis and smooth muscle prolifera-
tion, respectively, compared with allografts obtained from
RW-treated controls (Figure 3b and c). The expression of
aSMA, indicating myofibroblast accumulation in the grafts,
was mostly seen in the interstitial areas. There was no
definitive, aSMA-positive staining in the tubular epithelial
cells. Histopathology of the control isografts from the same
time point was similar to that of normal naı¨ve animals and
was not affected by HW administration (data not shown). In
addition, immunohistochemistry for both CD3 and CD68
revealed fewer graft-infiltrating T cells and macrophages,
respectively, in allografts obtained from HW-treated recipi-
ents compared with those obtained from RW-treated controls
(Figure 4a and b). These results proved to be statistically
significant when the number of positive-staining cells per
high-power field was counted for each sample (Figure 4c).
Taken in total, these histological results suggest that allografts
from HW-treated recipients experienced less CAN than did
those from RW-treated controls.
Oral administration of HW is an effective antioxidant strategy
in the setting of kidney allotransplantation
As mentioned previously, molecular hydrogen possesses potent
antioxidant properties. Furthermore, oxidant stress-induced
tissue damage is believed to be a common pathway in many of
the pathophysiological mechanisms involved in the develop-
ment of CAN. Therefore, owing to the fact that HW adminis-
tration resulted in increased local and systemic concentrations
of molecular hydrogen, as well as decreased histological
evidence of CAN in kidney allograft recipients compared with
RW-treated controls, we next determined whether the protec-
tion from CAN seen with HW administration was accom-
panied by a decrease in markers of oxidative tissue injury.
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Figure 2 |Hydrogen water (HW) administration improves
long-term survival after kidney allotransplantation.
(a) Although isograft recipients showed fair body weight gains
regardless of intake of HW, the recipients with allografts given
regular water (RW) gradually lost body weight by 60–80 days after
transplantation. The recipients given HW showed better body
weight gain compared with those without HW. (b) In correlation
with improved graft function, survival of allograft recipients
was significantly prolonged with oral administration
of HW. (Isograft given RW (Iso/RW), (n¼ 5); isograft given HW
(Iso/HW), (n¼ 5); allograft given RW (Allo/RW) (n¼ 13); allograft
given HW (Allo/HW) (n¼ 12); Kaplan-Meier, log-rank test,
Po0.05 Allo/RW vs Allo/HW).
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Tissue malondialdehyde (MDA) levels, which indicate lipid
peroxidation in cells and tissues, were significantly decreased
in allografts obtained 60 days posttransplantation from
HW-treated recipients compared with those obtained from
RW-treated controls (Figure 5a). Furthermore, immunohisto-
chemistry performed on allografts obtained from HW-treated
recipients exhibited less 4-hydroxy-2-nonenal (HNE) and
peroxynitrite staining compared with that seen in allografts
obtained from RW-treated controls (Figure 5b and c). These
results show that the local and systemic levels of molecular
hydrogen that are achieved through the administration of HW
are sufficient to effectively reduce oxidative stress-induced
tissue damage in the setting of kidney allotransplantation.
Oral administration of HW decreases the local production
of inflammatory markers in the setting of kidney
allotransplantation
One mechanism by which oxidative stress leads to the deve-
lopment of chronic rejection is by increasing the production
of inflammatory cytokines.26,27 Therefore, because HW
administration led to decreased oxidative stress and slowed
the progression toward CAN in kidney allografts, we next
determined whether HW treatment was also associated with
a decrease in local inflammatory cytokine production.
Quantitative reverse transcription PCR revealed significantly
lower levels of interleukin-6, tumor necrosis factor-a,
intracellular adhesion molecule-1, and interferon-g mRNA
in kidney allografts obtained from HW-treated recipients
60 days posttransplantation as compared with those obtained
from RW-treated controls (Figure 6a–d). These results
indicate that HW administration can attenuate the local
production of inflammatory markers in the setting of kidney
allotransplantation.
Oral administration of HW decreases the activation
of inflammatory signaling cascades after kidney
allotransplantation
Inflammatory intracellular signaling pathway activation
(most notably activation of mitogen-activated protein
kinases; MAP kinases) is a well-described event that contri-
butes to the progression of kidney allografts toward chronic
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Figure 3 |Hydrogen water (HW) administration decreases
chronic allograft nephropathy after kidney allotransplantation.
Hematoxylin/eosin (a), Masson’s trichome (b), or a-smooth muscle
actin (c) staining was performed 60 days posttransplantation to
assess histological and/or immunohistochemical evidence of
chronic allograft nephropathy. Images are representative of four
separate, individual grafts from each experimental group. Original
magnification  200. Allo/HW, allograft given HW; Allo/RW,
allograft given RW; RW, regular water.
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Figure 4 |Hydrogen water (HW) administration decreases
intragraft inflammatory cell infiltration after kidney
allotransplantation. CD3-positive (a) and CD68-positive (b)
infiltrating cells were assessed by immunohistochemistry
and quantitated as number of positive-staining cells per high-
power field (HPF) (original magnification  400) (c). Images are
representative of five individual animals for each group; (n¼ 5
for each group, original magnification  200, *Po0.05 versus
Allo/RW). Allo/HW, allograft given HW; Allo/RW, allograft given
RW; Iso HW, isograft given HW; Iso RW, isograft given RW; RW,
regular water.
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rejection.28–30 Oxidative stress can activate MAP kinase
signaling, which ultimately contributes to the proliferation
of mesangial cells in the setting of diabetic nephropathy.31
Mesangial cell proliferation is also involved in the develop-
ment of CAN. Therefore, we next determined whether HW
administration could suppress MAP kinase activation in the
kidney allografts. Western blot analysis showed that MAP
kinases, including c-Jun N-terminal kinase, p-38, extra-
cellular signal-regulated protein kinase as well as upstream
kinase cascades (MEK-1), were less activated in allografts
obtained from HW-treated recipients than in allografts
obtained from RW-treated recipients (Figure 7). These results
indicate that HW administration can inhibit intracellular
signaling pathways that are known to contribute to the
development of CAN in the setting of kidney transplantation
(Supplemental data).
DISCUSSION
In this study, we found that both allograft function and
overall survival were improved in rats that had been fed with
a diet supplemented with HW. Allografts from HW-treated
rats exhibited less infiltration of inflammatory cells and
suppressed activation of intragraft inflammatory signaling
pathways. The allografts from the HW-treated rats mani-
fested fewer markers of oxidative stress and, ultimately, fewer
progressed toward CAN as compared with controls. These
results indicate that HW represents a potentially novel
therapeutic strategy in the prevention of CAN in kidney
transplantation.
Molecular hydrogen is produced continuously under
normal physiological conditions, primarily during the
fermentation of nondigestible carbohydrates by intestinal
bacteria in the large intestine. This physiological production
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Figure 5 |Hydrogen water (HW) administration decreases
intragraft markers of oxidative stress after kidney
allotransplantation. (a) Intragraft malondialdehyde (MDA) levels
were quantitated using a commercially available kit. MDA levels in
the allografts treated with regular water (RW) increased 60 days
after transplantation. HW significantly reduced tissue MDA levels.
(n¼ 5, *Po0.05 vs Allo/RW). In addition, immunohisto-
chemistry for 4-hydroxy-2-nonenal (HNE) (b) and peroxynitrite
(c) was performed on formalin-fixed sections obtained from the
allograft groups. Oxidative injuries were more prominent in
the allografts given RW (Allo/RW) compared with those given
HW (Allo/HW). Arrows indicate HNE-positive cells. (Original
magnification  400; images are representative of three separate
experiments). Allo/HW, allograft given HW; Allo/RW, allograft
given RW; Iso HW, isograft given HW; Iso RW, isograft given RW.
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Figure 6 |Hydrogen water (HW) administration decreases
the intragraft production of inflammatory cytokines after
kidney allotransplantation. Interleukin-6 (IL-6) tumor necrosis
factor-a (TNFa) intracellular adhesion molecule-1 (ICAM-1), and
interferon-g (IFNg) mRNA levels in the kidney grafts taken
60 days after transplant were measured by real-time quantitative
reverse transcriptase PCR analysis. Although allograft rejection
caused upregulation of the mRNAs for these markers, HW
significantly reduced the mRNA levels as compared with regular
water (RW). (n¼ 5, *Po0.05 vs Allo/RW). Allo HW, allograft given
HW; Allo RW, allograft given RW; GAPDH, glyceraldehyde-3-
phosphate dehydrogenase; Iso HW, isograft given HW; Iso RW,
isograft given RW.
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of hydrogen gas may be responsible for the baseline levels of
hydrogen detected in circulation. It is excreted as flatus,
further metabolized by gut flora, or exhaled as a natural
component of abdominal gas. However, molecular hydrogen
has known physiological roles during conditions of home-
ostasis. Recent evidence indicates that inhaled hydrogen gas
has antioxidant and anti-apoptotic properties that can
protect organs from ischemia-reperfusion-induced injury by
selectively scavenging detrimental ROS. The mechanism of
action of inhaled hydrogen gas in these models involves its
ability to prevent oxidative damage, as indicated by decreased
nucleic acid oxidation and lipid peroxidation.20,21 Although
the concentration of gaseous molecular hydrogen used in the
above studies (B4%) is lower than the threshold at which it
is known to be flammable (4.6%), flammability is still a
realistic concern which may limit the translational appli-
cability of inhaled molecular hydrogen. Therefore, HW
represents a novel and easily translatable method of delivery
of molecular hydrogen. To our knowledge, this is the first
report describing the preventative effects of molecular
hydrogen, delivered in water containing therapeutic doses,
on the development of chronic rejection in the setting
of kidney allotransplantation and, as such, represents a
potentially novel and easily applicable solution to a difficult
clinical scenario (that is, CAN). The major novel findings of
the present study are that (i) HW improves allograft function
and overall survival by preventing CAN in a rodent model of
kidney transplantation, doing so in part by (ii) reducing
oxidative stress-induced damage and (iii) reducing the
activation of inflammatory signaling pathways and cytokine
production.
The basis for the present study was the fact that oxidative
stress is believed to be a common pathway that leads to the
development of chronic rejection in kidney transplantation.
As mentioned earlier, markers of oxidative stress are elevated
in kidney transplant recipients and, in contrast, markers of
antioxidant pathways are diminished. Mechanistically, ROS
activate inflammatory intracellular signaling pathways in
vascular smooth muscle cells,28 induce the epithelial-to-
mesenchymal transition,32,33 participate in extracellular matrix
deposition by mesangial cells,34 and contribute to renal tubular
atrophy through apoptosis35,36 and inflammation26,27—all
of which are key processes involved in the pathogenesis
of CAN.
Given the association described above between oxidative
stress and the development of CAN, the finding that HW
administration effectively decreases the intragraft accumula-
tion of markers of oxidative stress, such as MDA, 4-HNE, and
peroxynitrite, suggests that the antioxidant properties of
molecular hydrogen are likely to be responsible for the
beneficial effects on the allograft function and the prevention
of progression of CAN that were observed in this rat model
of kidney allotransplantation. We examined the intragraft
expression of tumor necrosis factor-a, interleukin-6, inter-
feron-g, and intracellular adhesion molecule-1 at the mRNA
level, as surrogate markers of the deleterious processes
downstream from oxidative damage, and found less expres-
sion of these inflammatory cytokines in HW-treated
recipients, which are well-described mediators of the
fibrogenesis phase of CAN.37 Furthermore, MAP kinase
signaling, which is known to be induced by oxidative damage
in the setting of kidney transplantation, was decreased in
HW-treated recipients. MAP kinase signaling contributes to
the development of CAN by mediating the action of growth
factors, such as transforming growth factor-b,38 participating
in the proliferation of vascular smooth muscle cells28 and the
extracellular matrix,29 and contributing to the intragraft
infiltration of mononuclear inflammatory cells through the
production of chemoattractants.30
Therefore, we conclude that HW, through its ability to act
as an effective method of delivery for molecular hydrogen,
can reduce the development of CAN in a rat model of kidney
allotransplantation. This improves allograft function and
overall survival in HW-treated recipients. The mechanism of
protection afforded to HW-treated recipients likely involves
the ability of molecular hydrogen to reduce oxidative stress-
induced damage, which is believed to be an upstream
mediator that contributes to the ultimate development of
CAN. Consequently, HW may be an effective and novel tool
in the clinical armamentarium against oxidative stress-
induced pathologies, in general, and CAN, in particular.
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Figure 7 |Hydrogen water (HW) administration decreases
intragraft inflammatory signaling cascade activation after
kidney allotransplantation. Western blot analysis showed that
mitogen-activated protein (MAP) kinases (JNK (c-Jun NH
2-terminal kinase), p38, ERK1/2 (extracellular signal-regulated
kinase 1/2)) and upstream kinase cascades (MEK-1), were less
activated in allografts obtained from recipients that were
HW-treated compared with those obtained from regular water
(RW)-treated recipients. Images are representative of three
independent experiments. Allo, allograft recipients; Iso, isograft
recipients; p, phosphorylated; t, total.
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MATERIALS AND METHODS
Animals
Inbred male Lewis (LEW, RT1l) and Brown Norway (BN, RT1n) rats
weighing 200–250 g were purchased from Harlan Sprague Dawley
(Indianapolis, IN, USA). Animals were maintained in cages in a
specific pathogen-free facility at the University of Pittsburgh and fed
a standard diet with free access to water. All procedures were
performed according to the guidelines of the Institutional Animal
Care and Use Committee at the University of Pittsburgh and the
National Research Council’s Guide for the Humane Care and Use of
Laboratory Animals.
Kidney transplantation
Orthotopic kidney transplantation was performed using a
previously described technique.39,40 In short, after intravenous
heparinization (300U), the donor’s left kidney was removed with
the left renal artery in continuity with a short aortic segment and the
left renal vein with a patch of vena cava. The excised graft was
flushed with 3ml of UW solution (Viaspan, Du Pont, Wilmington,
DE, USA). The left kidney graft was orthotopically transplanted into
the recipient by end-to-side microvascular anastomoses between
graft aorta and recipient infrarenal abdominal aorta, and between
graft renal vein and recipient infrarenal vena cava with 10-0 Micrin
suture. Both native kidneys of the recipient were removed, and end-
to-end ureteral anastomosis was performed using 10-0 Micrin
suture. Recipients received prophylactic antibiotics (Cefotetan
disodium, 100mg/kg, intramuscular injection) for 3 days after the
transplantation.
Oral administration of HW
Hydrogen water was produced by Blue Mercury (Tokyo, Japan)
using a HW-producing apparatus, by which molecular hydrogen gas
was dissolved in water under a pressure of 0.4MPa, as previously
described.23,24,41 The HW (500ml, hydrogen concentration
40.6mmol/l) was stored in an aluminum bag and placed in a
glass vessel twice a day. Control animals were treated with RW,
generated by degassing HW by gentle stirring for 24 h.
Determination of hydrogen levels in blood and tissue
Hydrogen water (3ml) was orally administered by gavage to naı¨ve
LEW rats or transplant recipients that had already been treated with
HW for 460 days. Arterial blood and kidney tissue were taken at
15, 30, and 60min after oral administration of HW. Blood or
homogenized kidney tissue was placed in a glass tube and air-phase
hydrogen levels were measured by gas-chromatography (Biogas
analyzer BAS-1000, Mitleben, Osaka, Japan).22
Experimental groups
Four experimental groups were analyzed: LEW to LEW syngeneic
grafts treated with RW (Group 1), LEW to LEW syngeneic grafts
treated with HW (Group 2), LEW to BN allogeneic grafts treated
with RW (Group 3), and LEW to BN allogeneic grafts treated with
HW (Group 4). Recipients of allografts received daily intramuscular
injections of tacrolimus (FK506, Astellas Pharmaceutical, Tokyo,
Japan) at a dose of 0.5mg/kg for 7 days (days 0–6), whereas those of
isografts received no immunosuppressant. Recipients were killed at
60 or 150 days after transplantation, and blood and kidney graft
samples were obtained after being cleared of blood by flushing with
Lactated Ringers solution. Kidney tissue was snap-frozen and stored
at 80 1C until use or fixed in 10% buffered formalin for routine
histopathology. For survival study experiments, recipient animals
were followed until recipient death due to graft failure or for 150
days after transplantation.
Evaluation of graft function
Renal graft function was assessed by measuring plasma creatinine
(P(Cr)) and blood urea nitrogen levels, as well as urinary protein
excretion and urinary creatinine (U(Cr)) levels using an auto-
analyzer (Beckman Instruments, Fullerton, CA, USA). Creatinine
clearance (CCr; ml/min) was calculated using the formula (CCr;
ml/min)¼ (U(Cr) urine volume)/(P(Cr) time). Urine samples
were collected using metabolic cage systems.
Histopathological analysis
Formalin-fixed graft tissues were paraffin embedded, cut into 5 mm
sections, and stained with hematoxylin/eosin, modified Masson’s
trichrome, or Verhoeff ’s elastic tissue stain (Rowley Biochemical
Institute, Danvers, MA, USA). Sections were also immunohisto-
chemically analyzed using the avidin–biotin–peroxidase complex
method after antigen retrieval and incubation with mouse anti-SMA
(a-SMA, DAKO, Carpinteria, CA, USA), monoclonal anti-rat
CD68 (ED1, Serotec, Raleigh, NC, USA), or monoclonal anti-rat
CD3 (Serotec), followed by incubation with LSAB þ horseradish
peroxidase (DAKO). Tissue oxidative injury was also assessed by
immunostaining with rabbit polyclonal anti-nitrotyrosine (Santa
Cruz Biotechnology, Santa Cruz, CA, USA) and mouse monoclonal
anti-4-HNE antibody (JAICA, Shizuoka, Japan), followed by
incubation with biotinylated anti-mouse IgG antibody (Vector
Laboratories, Burlingame, CA, USA) and avidin–biotin–peroxidase
complex (Vector Laboratories). Diaminobenzidine was used as the
peroxidase substrate. In each study, a set of sections was stained
without the primary antibody as a negative control.
Assessment of tissue MDA
Tissue MDA levels were assessed using the BIOXYTECH MDA-586
kit (OxisResearch, Portland, OR, USA), as previously described.42,43
Kidney samples were homogenized in buffer (pH 7.9) containing
5mmol/l butylated hydroxytoluene to prevent sample oxidation and
stored at 80 1C. Once all samples were collected, they were thawed
on ice and 10 mg of probucol was added to further minimize
oxidative reactions, then N-methyl-2-phenylindole (NMPI) in 25%
methanol and 75% acetonitrile were added to the supernatants,
followed by addition of 1 hydrogen chloride (HCL) and incubated
at 45 1C for 60min. A standard curve using 1,1,3,3-tetra-methoxy-
propane (TMOP), which generates free MDA during the acid
hydrolysis step, was also prepared. All samples and standards were
centrifuged (10,000 g, 10min) and absorbance at 586 nm was
measured using the Spectronic Biomate 3 (Thermo Scientific,
Waltham, MA, USA) according to the manufacturer’s protocol.
SYBR green real-time reverse transcription PCR
The levels of mRNAs for interleukin-6, intracellular adhesion
molecule-1, tumor necrosis factor-a, interferon-g, and glyceral-
dehyde-3-phosphate dehydrogenase were quantified in duplicate
using SYBR Green two-step, real-time reverse transcription PCR, as
previously described.42,43 Briefly, 1 mg of RNA from each sample was
used for reverse transcription with oligo dT primers (Invitrogen,
Carlsbad, CA, USA) and Superscript II enzyme (Invitrogen) to
generate first-strand cDNA. The PCR reaction mixture was prepared
using SYBR Green PCR Master Mix (PE Applied Biosystems, Foster
City, CA, USA). Each sample was analyzed in duplicate using the
conditions recommended by the manufacturer. Gene expression was
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normalized with glyceraldehyde-3-phosphate dehydrogenase mRNA
content.
Sodium dodecyl sulfate polyacrylamide gel electrophoresis
and western blots
Cytoplasmic protein was isolated from the kidney grafts, and
sodium dodecyl sulfate polyacrylamide gel electrophoresis was
performed using standard protocols. Total and phosphoprotein
levels were determined by western blot using primary rabbit
polyclonal antibodies and secondary goat anti-rabbit antibodies
(1:10,000, Pierce Chemical, Rockford, IL, USA), as previously
described.44 The following primary antibodies were used: anti-
phosphorylated-extracellular signal-regulated protein kinase1/2
and anti-total-extracellular signal-regulated protein kinase1/2 (Santa
Cruz), anti-phosphorylated-p38 MAP kinases, anti-phosphorylated-
c-Jun N-terminal kinase, anti-total-p38, anti-total-c-Jun N-terminal
kinase, anti-phosphorylated-MEK, and anti-total-MEK (all from
Cell Signaling Technology, Beverly, MA, USA).
Statistical analysis
Recipient survival was plotted using the Kaplan–Meier method, and
the differences between groups were analyzed using the log-rank test.
The other results were expressed as mean with standard deviation
(s.d.). Statistical analysis was performed using analysis of variance
(ANOVA) and the F-test with Bonferroni post hoc group comparisons,
where appropriate. A probability level of Po0.05 was considered to
be statistically significant with 95% confidence interval.
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